RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Cedarhurst, NY · New York, NY · Staten Island, NY · +42 more sites
Schizophrenia clinical trials in New York, NY
22 recruiting schizophrenia studies with a site in New York, NY.
RecruitingPhase 2NCT07410507
A Study of Brenipatide in Adult Participants With Schizophrenia
Sponsor: Eli Lilly and Company
New York, NY · +31 more sites
RecruitingPhase 2NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Sponsor: MapLight Therapeutics
New York, NY · +36 more sites
RecruitingPhase not listedNCT07101094
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Sponsor: Bristol-Myers Squibb
New York, NY · +19 more sites
RecruitingPhase 3NCT06229210
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Sponsor: Intra-Cellular Therapies, Inc.
New York, NY · Staten Island, NY · +57 more sites
RecruitingPhase 3NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Cedarhurst, NY · New York, NY · +47 more sites
RecruitingPhase 3NCT07227818
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Cedarhurst, NY · New York, NY · +19 more sites
RecruitingPhase 3NCT07184619
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Sponsor: Newron Pharmaceuticals SPA
New York, NY · +4 more sites
RecruitingPhase 3NCT07369154
52-week Open Label Safety-Tolerability Study
Sponsor: LB Pharmaceuticals Inc.
New York, NY · +22 more sites
RecruitingPhase 3NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Sponsor: Alkermes, Inc.
New York, NY · +25 more sites
RecruitingPhase 3NCT07565428
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
Sponsor: Minerva Neurosciences
New York, NY · +12 more sites
RecruitingPhase 1 / Phase 2NCT07423546
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Sponsor: New York State Psychiatric Institute
New York, NY
RecruitingPhase 4NCT06740890
Exercise and Olanzapine-samidorphan
Sponsor: New York State Psychiatric Institute
New York, NY
RecruitingNot applicableNCT06774417
Digital Strategies to Advance Help-Seeking - Aim 3
Sponsor: Columbia University
New York, NY
RecruitingNot applicableNCT07434479
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
Sponsor: Manhattan Psychiatric Center
New York, NY · White Plains, NY
RecruitingPhase not listedNCT06774430
Digital Strategies to Advance Help-Seeking Aim 1 and 2
Sponsor: Columbia University
New York, NY
RecruitingPhase 4NCT05208190
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Sponsor: New York State Psychiatric Institute
New York, NY · +4 more sites
RecruitingPhase 2NCT06502964
Study of ALTO-101 in Patients With Schizophrenia
Sponsor: Alto Neuroscience
New York, NY · +11 more sites
RecruitingNot applicableNCT05805397
Effectiveness of Motivation Skills Training (MST)
Sponsor: Columbia University
New York, NY
RecruitingPhase 3NCT03817502
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Sponsor: Gedeon Richter Plc.
Buffalo, NY · New York, NY · +7 more sites
RecruitingNot applicableNCT05389787
Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study
Sponsor: Northwell Health
New York, NY
Not yet recruitingNot applicableNCT07779226
DecNef for Auditory Verbal Hallucinations (AVH) in Schizophrenia
Sponsor: Columbia University
New York, NY
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.